Enhancing cardiovascular risk prediction through AI-enabled calcium-omics

Ammar Hoori1, Sadeer Al-Kindi2,3, Tao Hu1

  • 1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.

Scientific Reports
|May 15, 2024
PubMed

Insights

Novel calcium-omics features improve prediction of major adverse cardiovascular events (MACE) beyond the standard Agatston score. This advanced analysis identifies more high-risk patients for targeted therapies.

Area of Science:

  • Cardiovascular Imaging
  • Radiomics
  • Predictive Analytics

Background:

  • The Agatston score is a standard but limited predictor of major adverse cardiovascular events (MACE).
  • It does not capture detailed calcification features crucial for understanding coronary artery disease pathophysiology.
  • Individualized risk assessment requires analysis of calcification characteristics like number, distribution, and density.

Purpose of the Study:

  • To develop and validate a novel risk prediction model using detailed coronary artery calcification features (calcium-omics).
  • To compare the performance of the calcium-omics model against the traditional Agatston score for MACE prediction.
  • To identify specific calcium-omics features that are significant determinants of MACE risk.

Main Methods:

  • Utilized hand-crafted calcification features (calcium-omics) from 2457 CT calcium score (CTCS) images.
  • Employed Cox time-to-event modeling, elastic net, and synthetic sampling for imbalanced data.
  • Developed and validated a calcium-omics predictive model using an 80/20 training/testing split.

Main Results:

  • Calcium-omics features, including number of calcifications, LAD mass, and diffusivity, were key risk determinants.
  • Dense calcifications (>1000 HU) were associated with reduced MACE risk.
  • The calcium-omics model achieved superior performance (C-index 80.5%/71.6%, 2-year AUC 82.4%/74.8%) compared to Agatston, identifying 13.2% more MACE cases.

Conclusions:

  • Calcium-omics offers improved risk prediction for MACE compared to the conventional Agatston score.
  • This novel approach enhances identification of patients requiring intensive cardiovascular follow-up and treatment.
  • Further multi-institutional studies are warranted to validate and implement calcium-omics in clinical practice.